Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in AURA — Aura Biosciences, Inc.

CIK 1037389 NEW YORK, NY
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,236,820
+$553,771 QoQ
Shares Held
174,200
+70.6% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 146 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. AURA ranks #166 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in AURA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,236,820 174,200
2026-03-31 $683,049 102,100
2025-12-31 $791,340 145,200
2025-09-30 $603,217 97,608
2025-06-30 $823,490 131,548
2025-03-31 $605,338 103,300
2024-12-31 $688,014 83,700
2024-09-30 $126,522 14,200
2024-06-30 $545,076 72,100
2024-03-31 $448,235 57,100
2023-12-31 $252,510 28,500
2023-09-30 $121,095 13,500
2023-06-30 $240,825 19,500
2023-03-31 $93,728 10,100
2022-12-31 $137,550 13,100